首页> 外文期刊>Molecular neurodegeneration >Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction
【24h】

Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction

机译:HN10细胞中诱导型突变亨廷顿蛋白表达重现亨廷顿氏病样神经元功能障碍

获取原文
           

摘要

Background Expansion of a polyglutamine repeat at the amino-terminus of huntingtin is the probable cause for Huntington's disease, a lethal progressive autosomal-dominant neurodegenerative disorders characterized by impaired motor performance and severe brain atrophy. The expanded polyglutamine repeat changes the conformation of huntingtin and initiates a range of pathogenic mechanisms in neurons including intracellular huntingtin aggregates, transcriptional dysregulation, energy metabolism deficits, synaptic dystrophy and ultimately neurodegeneration. It is unclear how these events relate to each other or if they can be reversed by pharmacological intervention. Here, we describe neuronal cell lines expressing inducible fragments of normal and mutant huntingtin. Results In HN10 cells, the expression of wild type and mutant huntingtin fragments was dependent on the induction time as well as on the concentration of the RheoSwitch? inducing ligand. In order to analyze the effect of mutant huntingtin expression on cellular functions we concentrated on the 72Q exon1 huntingtin expressing cell line and found that upon induction, it was possible to carefully dissect mutant huntingtin-induced phenotypes as they developed over time. Dysregulation of transcription as a result of mutant huntingtin expression showed a transcription signature replicating that reported in animal models and Huntington's disease patients. Crucially, triggering of neuronal differentiation in mutant huntingtin expressing cell resulted in the appearance of additional pathological hallmarks of Huntington's disease including cell death. Conclusion We developed neuronal cell lines with inducible expression of wild type and mutant huntingtin. These new cell lines represent a reliable in vitro system for modeling Huntington's disease and should find wide use for high-throughput screening application and for investigating the biology of mutant huntingtin.
机译:背景亨廷顿病氨基末端的聚谷氨酰胺重复序列的扩增是亨廷顿氏病的可能原因,亨廷顿氏病是一种致命的进行性常染色体显性神经退行性疾病,其特征是运动功能受损和严重的脑萎缩。扩展的聚谷氨酰胺重复序列改变了亨廷顿蛋白的构象,并引发了神经元中的一系列致病机制,包括细胞内亨廷顿蛋白聚集,转录失调,能量代谢缺陷,突触营养不良和最终神经变性。尚不清楚这些事件之间如何相互关联,或者是否可以通过药理干预逆转它们。在这里,我们描述了表达正常和突变亨廷顿蛋白的诱导片段的神经元细胞系。结果在HN10细胞中,野生型和突变型亨廷顿蛋白片段的表达取决于诱导时间以及RheoSwitch?的浓度。诱导配体。为了分析突变亨廷顿蛋白表达对细胞功能的影响,我们集中在表达72Q外显子1亨廷顿蛋白的细胞系上,发现在诱导后,随着它们随着时间的发展,可能会仔细解剖突变亨廷顿蛋白诱导的表型。由于突变亨廷顿蛋白表达而导致的转录失调显示了转录签名的复制,该复制签名已在动物模型和亨廷顿舞蹈病患者中报道。至关重要的是,突变亨廷顿表达细胞中神经元分化的触发导致出现亨廷顿氏病的其他病理学特征,包括细胞死亡。结论我们开发了可诱导表达野生型和突变亨廷顿蛋白的神经元细胞系。这些新的细胞系代表了用于建模亨廷顿氏病的可靠体外系统,应在高通量筛选应用和研究突变亨廷顿病的生物学研究中得到广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号